antibody

Biotin-Linked Polyclonal Antibody to TNF Receptor Associated Factor 6 (TRAF6)

MBS2096252

0.1 mg

245 USD

polyclonal

rabbit

biotin

western blot, immunohistochemistry, immunocytochemistry, immunoprecipitation

Antibody

Biotin-Linked Polyclonal Antibody to TNF Receptor Associated Factor 6 (TRAF6)

[TNF Receptor Associated Factor 6 (TRAF6)]

[RNF85; E3 ubiquitin-protein ligase TRAF6; Interleukin-1 signal transducer]

[TNF receptor-associated factor 6; TNF receptor-associated factor 6; TNF receptor-associated factor 6; TNF receptor associated factor 6; E3 ubiquitin-protein ligase TRAF6; Interleukin-1 signal transducer; RING finger protein 85; RING-type E3 ubiquitin transferase TRAF6Curated]

[TRAF6]

[TRAF6; TRAF6; RNF85; MGC:3310; RNF85]

Polyclonal

Rabbit

Antigen-specific Affinity Chromatography.

Supplied as solution form in 0.01M PBS, pH7.4, containing 0.02% NaN3, 50% glycerol.

0.47 mg/ml

Storage: Avoid repeated freeze/thaw cycles. Store at 4°C for frequent use. Aliquot and store at -20°C for 12 months. Stability Test: The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37°C for 48h, and no obvious degradation and precipitation were observed. The loss rate is less than 5% within the expiration date under appropriate storage condition.

WB; IHC; ICC; IP.

Western blotting: 0.5-2 ug/mL;1:230-940. Immunohistochemistry: 5-20 ug/mL;1:23-94. Immunocytochemistry: 5-20 ug/mL;1:23-94. Optimal working dilutions must be determined by end user.

Knockout Validation

Conjugation: Biotin

Immunogen: TRAF6 (Ala153~Pro423)

22027630

NP_665802.1

NM_145803.2

Q9Y4K3

Activated TLR4 Signalling Pathway (106400); Adaptive Immune System Pathway (366160); Apoptosis Modulation And Signaling Pathway (198822); BCR Signaling Pathway (138058); BDNF Signaling Pathway (712093); CD40/CD40L Signaling Pathway (138061); Canonical NF-kappaB Pathway (138030); Cell Death Signalling Via NRAGE, NRIF And NADE Pathway (106443); Chagas Disease (American Trypanosomiasis) Pathway (147809); Chagas Disease (American Trypanosomiasis) Pathway (147795)

The protein encoded by this gene is a member of the TNF receptor associated factor (TRAF) protein family. TRAF proteins are associated with, and mediate signal transduction from, members of the TNF receptor superfamily. This protein mediates signaling from members of the TNF receptor superfamily as well as the Toll/IL-1 family. Signals from receptors such as CD40, TNFSF11/RANCE and IL-1 have been shown to be mediated by this protein. This protein also interacts with various protein kinases including IRAK1/IRAK, SRC and PKCzeta, which provides a link between distinct signaling pathways. This protein functions as a signal transducer in the NF-kappaB pathway that activates IkappaB kinase (IKK) in response to proinflammatory cytokines. The interaction of this protein with UBE2N/UBC13, and UBE2V1/UEV1A, which are ubiquitin conjugating enzymes catalyzing the formation of polyubiquitin chains, has been found to be required for IKK activation by this protein. This protein also interacts with the transforming growth factor (TGF) beta receptor complex and is required for Smad-independent activation of the JNK and p38 kinases. This protein has an amino terminal RING domain which is followed by four zinc-finger motifs, a central coiled-coil region and a highly conserved carboxyl terminal domain, known as the TRAF-C domain. Two alternatively spliced transcript variants, encoding an identical protein, have been reported. [provided by RefSeq, Feb 2012]

TRAF6: E3 ubiquitin ligase that, together with UBE2N and UBE2V1, mediates the synthesis of 'Lys-63'-linked-polyubiquitin chains conjugated to proteins, such as IKBKG, AKT1 and AKT2. Also mediates ubiquitination of free/unanchored polyubiquitin chain that leads to MAP3K7 activation. Leads to the activation of NF- kappa-B and JUN. May be essential for the formation of functional osteoclasts. Seems to also play a role in dendritic cells (DCs) maturation and/or activation. Represses c-Myb-mediated transactivation, in B-lymphocytes. Adapter protein that seems to play a role in signal transduction initiated via TNF receptor, IL- 1 receptor and IL-17 receptor. Regulates osteoclast differentiation by mediating the activation of adapter protein complex 1 (AP-1) and NF-kappa-B, in response to RANK-L stimulation. Homotrimer. Homooligomer. N-terminal region is dimeric while C-terminal region is trimeric; maybe providing a mode of oligomerization. Binds to TNFRSF5/CD40 and TNFRSF11A/RANK. Associates with NGFR, TNFRSF17, IRAK1, IRAK2, IRAK3, IRAK4, RIPK2, MAP3K1, MAP3K5, MAP3K14, CSK, TRAF, TRAF-interacting protein TRIP and TNF receptor associated protein TDP2. Interacts with IL17R. Interacts with SQSTM1 bridging NTRK1 and NGFR. Forms a ternary complex with SQSTM1 and PRKCZ. Interacts with PELI1, PELI2 and PELI3. Binds UBE2V1. Interacts with MAVS/IPS1. Interacts with TAX1BP1. Interacts with IL1RL1. Interacts with TRAFD1. Interacts with ZNF675. Interacts with AJUBA. Interacts with TICAM1 and TICAM2. Interacts with ZFAND5. Interacts with ARRB1 and ARRB2. Interacts with MAP3K7 and TAB1/MAP3K7IP1; during IL-1 signaling. Interacts with UBE2N. Interacts with TGFBR1, HDAC1 and RANGAP1. Interacts with AKT1, AKT2 and AKT3. Interacts (via TRAF domains) with NUMBL (via C-terminal). Interacts (via TRAF domains) with WDR34 (via WD domains). Interacts with RBCK1. Interacts with TRAF3IP2. Interacts with LIMD1 (via LIM domains). Expressed in heart, brain, placenta, lung, liver, skeletal muscle, kidney and pancreas. Belongs to the TNF receptor-associated factor family. A subfamily. Protein type: EC 6.3.2.-; Ligase; Ubiquitin conjugating system; Ubiquitin ligase. Chromosomal Location of Human Ortholog: 11p12. Cellular Component: cell cortex; cytoplasm; cytoplasmic side of plasma membrane; cytosol; endosome membrane; lipid droplet; nucleus; perinuclear region of cytoplasm; plasma membrane; protein complex. Molecular Function: histone deacetylase binding; identical protein binding; mitogen-activated protein kinase kinase kinase binding; protein binding; protein kinase B binding; protein kinase binding; protein N-terminus binding; thioesterase binding; tumor necrosis factor receptor binding; ubiquitin conjugating enzyme binding; ubiquitin protein ligase binding; ubiquitin-protein transferase activity; zinc ion binding. Biological Process: activation of MAPK activity; activation of NF-kappaB-inducing kinase; activation of protein kinase activity; antigen processing and presentation of exogenous peptide antigen via MHC class II; bone resorption; cell development; cellular response to DNA damage stimulus; I-kappaB kinase/NF-kappaB signaling; JNK cascade; membrane protein intracellular domain proteolysis; MyD88-dependent toll-like receptor signaling pathway; MyD88-independent toll-like receptor signaling pathway; myeloid dendritic cell differentiation; negative regulation of apoptosis; negative regulation of transcription from RNA polymerase II promoter; negative regulation of transcription, DNA-dependent; neural tube closure; odontogenesis of dentine-containing teeth; ossification; osteoclast differentiation; positive regulation of apoptosis; positive regulation of I-kappaB kinase/NF-kappaB signaling; positive regulation of interleukin-12 biosynthetic process; positive regulation of interleukin-2 production; positive regulation of interleukin-6 biosynthetic process; positive regulation of JUN kinase activity; positive regulation of lipopolysaccharide-mediated signaling pathway; positive regulation of NF-kappaB transcription factor activity; positive regulation of osteoclast differentiation; positive regulation of protein ubiquitination; positive regulation of smooth muscle cell proliferation; positive regulation of T cell activation; positive regulation of T cell cytokine production; positive regulation of T cell proliferation; positive regulation of transcription factor activity; positive regulation of transcription from RNA polymerase II promoter; protein autoubiquitination; protein complex assembly; protein deubiquitination; protein polyubiquitination; regulation of immunoglobulin secretion; stimulatory C-type lectin receptor signaling pathway; T cell receptor signaling pathway; T-helper 1 type immune response; toll-like receptor 9 signaling pathway; toll-like receptor signaling pathway

0.1 mg

245 USD

0.2 mg

370

1 mg

880